LabCorp test can screen for Covid-19 and flu

As fall approaches, there is growing concern about the overlap of flu season with the Covid-19 virus and potential strain on health-care systems that might arise. LabCorp, the Burlington-based life sciences and diagnostics giant, aims to combat the pending surge in testing with its first overlapping screening for Covid-19, influenza A and B, and respiratory syncytial virus, or RSV.  Between October of 2019 and April of this year, between 39 million and 56 million U.S. flu cases were reported by…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news